What are the potential side effects of NHL - Diffuse Large B-Cell treatments

Potential Side Effects of DLBCL Treatments

I'm glad you're preparing to understand what to expect. Let me explain the common side effects associated with the main treatments used for diffuse large B-cell lymphoma (DLBCL).

---

How Doctors Approach Side Effect Management

According to the NCCN Guidelines for B-Cell Lymphomas, oncologists:

• Discuss potential side effects before starting treatment
• Monitor you closely during and after treatment
• Have strategies to manage or prevent many side effects
• Adjust treatment if side effects become severe

---

MAIN TREATMENT APPROACHES & THEIR SIDE EFFECTS

1. R-CHOP (Most Common First-Line Treatment)

R-CHOP combines rituximab (anti-CD20 antibody) with four chemotherapy drugs. Here are the potential side effects:

Short-Term Side Effects (During/Shortly After Treatment)

Infusion Reactions (from rituximab):

• Fever, chills, flushing
• Shortness of breath
• Chest tightness
• Usually occur during first infusion and decrease with subsequent doses
• Doctors can premedicate to prevent these

Nausea & Vomiting:

• Very common with chemotherapy
• Managed with anti-nausea medications (antiemetics)
• Usually improves with each cycle

Low Blood Counts (Myelosuppression):

• Low white blood cells (neutropenia): Increases infection risk
• Low red blood cells (anemia): Causes fatigue, shortness of breath
• Low platelets (thrombocytopenia): Increases bleeding/bruising risk
• Typically recover between treatment cycles
• Doctors monitor with blood tests (CBC) before each cycle

Fatigue:

• Very common during chemotherapy
• Usually improves after treatment ends
• Can last weeks to months

Hair Loss:

• Occurs with doxorubicin (the "A" in CHOP)
• Usually reversible after treatment ends
• Varies in severity

Mouth Sores (Mucositis):

• Painful ulcers in mouth/throat
• Managed with special rinses and pain relief
• Usually resolves after treatment

Longer-Term Side Effects

Heart Problems (Cardiotoxicity):

• Doxorubicin can affect heart function
• Doctors monitor with echocardiograms or MUGA scans before/during treatment
• Risk increases with higher cumulative doses
• Usually reversible if caught early

Nerve Damage (Peripheral Neuropathy):

• From vincristine (the "O" in CHOP)
• Numbness, tingling, weakness in hands/feet
• Usually improves after treatment but can be long-lasting
• Severity varies

Secondary Cancers:

• Rare but possible years after treatment
• Risk is generally low with modern DLBCL treatment
• Doctors weigh this against the benefit of treating the lymphoma

Infertility:

• Chemotherapy can affect fertility in both men and women
• Discuss fertility preservation options before starting treatment if this is important to you

---

2. Rituximab (Anti-CD20 Antibody)

When used alone or as part of R-CHOP:

Common Side Effects:

• Infusion reactions (fever, chills, shortness of breath) – usually with first dose
• Fatigue
• Headache
• Low blood counts (less severe than with full chemotherapy)

Rare but Serious:

• Tumor lysis syndrome (TLS) – when lymphoma cells die rapidly and release contents into bloodstream
  • Symptoms: nausea, vomiting, diarrhea, muscle cramps, shortness of breath
  • Prevented with hydration and medications (allopurinol or febuxostat)
• Reactivation of hepatitis B virus (if you carry it)

---

3. Other Chemotherapy Regimens

R-EPOCH (used for some DLBCL patients):

• Similar side effects to R-CHOP
• Continuous infusion may cause different toxicity patterns

Bendamustine-based regimens:

• Nausea/vomiting
• Low blood counts
• Fatigue
• Infusion reactions

---

4. Targeted Therapies (for specific DLBCL subtypes)

For CD30+ DLBCL (Brentuximab vedotin):

• Peripheral neuropathy (nerve damage)
• Infusion reactions
• Low blood counts

For MYC+ DLBCL or other molecular subtypes:

• Side effects depend on specific drug used
• Your doctor will discuss these if relevant to your case

---

5. Radiation Therapy (if used)

Short-term:

• Skin irritation (like sunburn)
• Fatigue
• Nausea (if abdomen treated)

Long-term:

• Secondary cancers (rare)
• Heart/lung damage (if chest treated)
• Infertility (if pelvis treated)

---

Managing Side Effects: What Your Care Team Does

According to NCCN Guidelines and ASCO recommendations, your oncology team will:

✓ Prevent side effects when possible:

• Pre-medications before chemotherapy
• Anti-nausea medications
• Growth factors to boost white blood cells if needed
• Hydration protocols

✓ Monitor closely:

• Blood tests before each treatment
• Physical exams
• Imaging as needed
• Heart function tests (echocardiogram/MUGA)

✓ Manage side effects:

• Adjust doses if needed
• Change medications
• Delay treatment if blood counts too low
• Refer to specialists (cardiologist, neurologist, etc.) if needed

---

Important Factors That Affect Side Effects

Your individual side effect experience depends on:

• Your age and overall health
• Other medical conditions (heart disease, diabetes, etc.)
• Other medications you're taking
• Specific DLBCL subtype (GCB vs. ABC, MYC status, etc.)
• Stage of disease
• Treatment regimen chosen

---

Questions to Ask Your Oncology Team

To prepare for YOUR specific treatment:

1. Which specific treatment regimen is recommended for my DLBCL, and what are the most common side effects I should expect?

2. What side effects are most likely to occur, and which ones are most serious?

3. What medications or strategies will you use to prevent or manage side effects?

4. How will you monitor for serious side effects like heart problems or infections?

5. If I experience side effects, when should I contact you versus going to the emergency room?

6. Are there any side effects that might require me to stop or delay treatment?

7. What support services are available (nutritionist, social worker, support groups)?

8. How long do side effects typically last after treatment ends?

9. Are there any long-term side effects I should watch for after treatment is complete?

10. Should I discuss fertility preservation before starting treatment?

---

Authoritative Sources

This information is based on:

• NCCN Guidelines for B-Cell Lymphomas, Version 3.2025 – specifically DLBCL toxicity management sections
• ASCO Guidelines on Chemotherapy Toxicity Management
• American Cancer Society cancer treatment side effect resources
• National Cancer Institute (NCI) patient education materials on lymphoma treatment

---

Important Reminders

• Not everyone experiences all side effects – your experience will be individual
• Most side effects are manageable with proper medical support
• Your oncology team is experienced in preventing and managing these side effects
• Communication is key – report any symptoms to your care team promptly
• Side effects don't mean treatment isn't working – they're often a sign your body is responding to the medication

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.